Instructions for Authors

1. Aim and scope

Journal of pharmaceutical sciences and research (JPSR) is an international peer-
reviewed multidisciplinary online journal publishing original research articles in
pharmaceutical fields (pharmaceutics, pharmaceutical technology, pharmaceutical chemistry,
pharmaceutical analysis, medicinal chemistry, biopharmaceutics, pharmacokinetics,
pharmacology, toxicology, genomics and proteomics, pharmacognosy and phytochemistry)
and scheduled to appear monthly. The journal accepts Review Articles, Original Articles and
Short Communications.
2. Submission of Manuscript
Authors are invited to submit their manuscripts electronically through Journal's email
address ([email protected]) along with a covering letter preferably by the corresponding
author or first author. Each manuscript will be provided with a manuscript ID and all
correspondence is done through e-mail. Please always refer to the manuscript ID for any
further enquiries.
3. Organization of Manuscript
Manuscript should be typewritten in 12 font size, double-spaced, with margins of at
least one inch on all sides. Pages should be numbered consecutively, starting with the title
page and the matter arranged in the following order: Title page, Sections (Abstract,
Keywords, Introduction, Materials and Methods, Results, Discussion or Results and
Discussion, Conclusions), Acknowledgements, References, Illustrations (Tables and figures
along with caption and legends) and Tables and Figures captions and legends. Original
Articles should have more than 14 pages, Review Articles in the range of 14-30 pages and
Short Communications up to 14 pages, inclusive of illustrations.
3.1 Title Page: Title page contains title of the manuscript in bold face, title case (font size
14), names of the authors in normal face, title case (font size 12) followed by the address of
authors in normal face, lower case (font size 12). Names of the authors should appear as
initials followed by surnames. Full names may be given in some instances to avoid confusion.
Followed by the author names, please provide the complete postal address or addresses with
pin code number of the place(s), where the research work has been carried out. If the
publication originates from several institutes, the affiliation of each author should be clearly
stated by using superscript Arabic numbers after the name and before the institute. The author
to whom correspondence should be directed must be indicated with an asterisk. At the bottom
left corner of this page, please mention “*For correspondence” and provide a functional e-
mail address of the corresponding author to whom all correspondence (including galley
proofs) is to be sent.
3.2 Sections: Manuscripts should be divided into the following section titles (normal face,
upper case) and subtitles in each section (bold face, lower case):
Abstract: An abstract not exceeding 250 words (for Short Communications between 60 and
80 words) should be provided typed on a separate sheet. Abstract should include aims,
methods, results and conclusion.
Keywords: Up to 4-6 keywords must be provided in alphabetical order, preferably taken from
Index Medicus. These keywords should be typed at the end of the abstract.

1
Introduction: It should be a concise statement of the background to the work presented,
including relevant earlier work, suitably referenced. It should be started in a separate page
after keywords.
Materials and Methods: It shall be started as a continuation to introduction on the same page.
All important materials and equipments, the manufacturer’s name and, if possible, the
location should be provided. The main methods used shall be briefly described, citing
references. New methods or substantially modified methods may be described in sufficient
detail. The statistical method and the level of significance chosen shall be clearly stated.
Results: The important results of the work should be clearly stated and illustrated where
necessary by tables and figures. The statistical treatment of data and significance level of the
factors should be stated wherever necessary. Data that is not statistically significant need only
to be mentioned in the text - no illustration is necessary.
Discussion: This section should deal with the interpretation of results, making the readers to
understanding of the problem taken and should be logical. The discussion should state the
scope of the results, which need to be further explored. Results and discussion of the work
can also be combined under one section, Results and Discussion.
Conclusions: Concisely summarizes the principal conclusions of the work and highlights the
wider implications. This section should not merely duplicate the abstract.
3.3 Acknowledgements: Acknowledgements as well as information regarding funding
sources should be provided.
3.4 References: Citations of literature within the text must be presented in numerical order
and should be set in square brackets, thus [1, 12]. The cited literature are also collected in
numerical order at the end of the manuscript under the heading “References”. Titles of
journals should be abbreviated according to the practice of Chemical Abstracts. The
abbreviated title and the volume number should appear in italics. Only the papers and books
that have been published or in press may be cited. Please give the DOI (Digital Object
Identifier) if the paper is not yet in print. Please note that website addresses must not be
included as a reference, but should be inserted in the text directly after the information to
which they refer.
Please note the following examples.
Journals:
[1] Meredith, P. A., Elliott, H. L., Clin. Pharmacokinet. 1992, 22, 22 – 31.
[2] Yamamoto, K., Hagino, M., Kotaki, H., Iga, T., J. Chromatogr. B 1998, 720,
251 – 255.
Books:
[1] Myers, R. H., Montgomery, D., Response Surface Methodology, Wiley, New York
1995.
Chapter in a book:
[1] Crowther, J. B., in: Ahuja, S., Scypinski, S. (Eds.), Handbook of Modern
Pharmaceutical Analysis, Academic Press, New York 2001, pp. 415 – 443.

3.5 Tables: Should each be typed on a separate page, numbered in sequence with the body of
the text. Tables should be headed with a short, descriptive caption. They should be formatted
with horizontal lines only: vertical ruled lines are not required. Footnotes to tables should be
indicated with a), b), c) etc. and typed on the same page as the table.
3.6 Figures: Should be on separate pages but not inserted with in the text. All figures must be
referred to in the text and numbered with Arabic numerals in the sequence in which they are

2
cited. Each figure must be accompanied by a legend explaining in detail the contents of the
figure and are to be typed under the figures. Graphs and bar graphs should preferably be
prepared using Microsoft Excel and submitted as Excel graph pasted in Word. Alternatively
photographs can be submitted as JPEG images. Keys to symbols, abbreviations, arrows,
numbers or letters used in the illustrations should not be written on the illustration itself but
should be clearly explained in the legend. Avoid inserting a box with key to symbols, in the
figure or below the figure. All Tables and Figures captions and legends should be typed on a
separate page.
4. Article Proofs
Page proofs are sent to the designated author through e-mail. They must be carefully
checked and returned the revised manuscript within 48 hours of receipt.
5. Copyright
Authors are asked to sign a warranty and copyright agreement upon acceptance of
their manuscript, before the manuscript can be published. The Copyright Transfer Agreement
can be downloaded here (in editable PDF).
Submission of your paper to this journal implies that the paper is not under
submission for publication elsewhere. Material which has been previously copyrighted,
published, or accepted for publication will not be considered for publication in this journal.
Submission of a manuscript is interpreted as a statement of certification that no part of the
manuscript is copyrighted by any other publisher nor is under review by any other formal
publication. By submitting your manuscript to us, you agree on Pharma Info Publisher
copyright guidelines. It is your responsibility to ensure that your manuscript does not cause
any copyright infringements, defamation, and other problems. Submitted papers are assumed
to contain no proprietary material unprotected by patent or patent application; responsibility
for technical content and for protection of proprietary material rests solely with the author(s)
and their organizations and is not the responsibility of the Pharma Info Publisher or its
Editorial Staff. The main author is responsible for ensuring that the article has been seen and
approved by all the other authors. It is the responsibility
of the author to obtain all necessary copyright release permissions for the use of any
copyrighted materials in the manuscript prior to the submission.
6. Page Charges and Re-print
The journals published by Pharma Info Publisher are Open Access journals, which
mean that the publication cost should be covered by the author's institution or research funds.